<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB03647</drugbank-id>
  <drugbank-id>EXPT01914</drugbank-id>
  <name>3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid</name>
  <description/>
  <cas-number/>
  <unii/>
  <average-mass>379.472</average-mass>
  <monoisotopic-mass>379.124214233</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring.</description>
    <direct-parent>Benzamides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Benzenoids</superclass>
    <class>Benzene and substituted derivatives</class>
    <subclass>Benzoic acids and derivatives</subclass>
    <alternative-parent>2,3,5-trisubstituted thiophenes</alternative-parent>
    <alternative-parent>Benzoyl derivatives</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organooxygen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Tertiary carboxylic acid amides</alternative-parent>
    <alternative-parent>Thiophene carboxylic acids</alternative-parent>
    <alternative-parent>Vinylogous amides</alternative-parent>
    <alternative-parent>p-Toluamides</alternative-parent>
    <substituent>2,3,5-trisubstituted thiophene</substituent>
    <substituent>Aromatic heteromonocyclic compound</substituent>
    <substituent>Benzamide</substituent>
    <substituent>Benzoyl</substituent>
    <substituent>Carboxamide group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>P-toluamide</substituent>
    <substituent>Tertiary carboxylic acid amide</substituent>
    <substituent>Thiophene</substituent>
    <substituent>Thiophene carboxylic acid</substituent>
    <substituent>Thiophene carboxylic acid or derivatives</substituent>
    <substituent>Toluamide</substituent>
    <substituent>Toluene</substituent>
    <substituent>Vinylogous amide</substituent>
  </classification>
  <salts/>
  <synonyms/>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1yvx</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>4.64</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-5.5</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.09e-03 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>5.43</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>5-phenyl-3-[N-(propan-2-yl)4-methylbenzamido]thiophene-2-carboxylic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>3-(N-isopropyl4-methylbenzamido)-5-phenylthiophene-2-carboxylic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>379.472</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>379.124214233</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC(C)N(C(=O)C1=CC=C(C)C=C1)C1=C(SC(=C1)C1=CC=CC=C1)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C22H21NO3S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C22H21NO3S/c1-14(2)23(21(24)17-11-9-15(3)10-12-17)18-13-19(27-20(18)22(25)26)16-7-5-4-6-8-16/h4-14H,1-3H3,(H,25,26)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>LRHXIDOGMBZJFN-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>57.61</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>107.98</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>40.7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.56</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-2.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>43541</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>503535</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507123</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>439726</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50139688</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>IPC</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL168083</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001729</id>
      <name>Genome polyprotein</name>
      <organism/>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P26660" source="Swiss-Prot">
        <name>Genome polyprotein</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Core protein packages viral RNA to form a viral nucleocapsid, and promotes virion budding. Modulates viral translation initiation by interacting with HCV IRES and 40S ribosomal subunit. Also regulates many host cellular functions such as signaling pathways and apoptosis. Prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) and IFN-gamma signaling pathways and by inducing human STAT1 degradation. Thought to play a role in virus-mediated cell transformation leading to hepatocellular carcinomas. Interacts with, and activates STAT3 leading to cellular transformation. May repress the promoter of p53, and sequester CREB3 and SP110 isoform 3/Sp110b in the cytoplasm. Also represses cell cycle negative regulating factor CDKN1A, thereby interrupting an important check point of normal cell cycle regulation. Targets transcription factors involved in the regulation of inflammatory responses and in the immune response: suppresses NK-kappaB activation, and activates AP-1. Could mediate apoptotic pathways through association with TNF-type receptors TNFRSF1A and LTBR, although its effect on death receptor-induced apoptosis remains controversial. Enhances TRAIL mediated apoptosis, suggesting that it might play a role in immune-mediated liver cell injury. Seric core protein is able to bind C1QR1 at the T-cell surface, resulting in down-regulation of T-lymphocytes proliferation. May transactivate human MYC, Rous sarcoma virus LTR, and SV40 promoters. May suppress the human FOS and HIV-1 LTR activity. Alters lipid metabolism by interacting with hepatocellular proteins involved in lipid accumulation and storage. Core protein induces up-regulation of FAS promoter activity, and thereby probably contributes to the increased triglyceride accumulation in hepatocytes (steatosis) (By similarity).E1 and E2 glycoproteins form a heterodimer that is involved in virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. E1/E2 heterodimer binds to human LDLR, CD81 and SCARB1/SR-BI receptors, but this binding is not sufficient for infection, some additional liver specific cofactors may be needed. The fusion function may possibly be carried by E1. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection (By similarity).P7 seems to be a heptameric ion channel protein (viroporin) and is inhibited by the antiviral drug amantadine. Also inhibited by long-alkyl-chain iminosugar derivatives. Essential for infectivity (By similarity).Protease NS2-3 is a cysteine protease responsible for the autocatalytic cleavage of NS2-NS3. Seems to undergo self-inactivation following maturation (By similarity).NS3 displays three enzymatic activities: serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS4A, is responsible for the cleavages of NS3-NS4A, NS4A-NS4B, NS4B-NS5A and NS5A-NS5B. NS3 RNA helicase binds to RNA and unwinds dsRNA in the 3' to 5' direction, and likely RNA stable secondary structure in the template strand. Cleaves the host antiviral protein MAVS (By similarity). NS3/NS4A complex also prevents phosphorylation of human IRF3, thus preventing the establishment of dsRNA induced antiviral state.NS4B induces a specific membrane alteration that serves as a scaffold for the virus replication complex. This membrane alteration gives rise to the so-called ER-derived membranous web that contains the replication complex (By similarity).NS5A is a component of the replication complex involved in RNA-binding. Its interaction with Human VAPB may target the viral replication complex to vesicles. Down-regulates viral IRES translation initiation. Mediates interferon resistance, presumably by interacting with and inhibiting human EIF2AK2/PKR. Seems to inhibit apoptosis by interacting with BIN1 and FKBP8. The hyperphosphorylated form of NS5A is an inhibitor of viral replication (By similarity).NS5B is an RNA-dependent RNA polymerase that plays an essential role in the virus replication.</specific-function>
        <gene-name/>
        <locus/>
        <cellular-location>Host endoplasmic reticulum membrane</cellular-location>
        <transmembrane-regions>169-189
359-379
730-750
762-782
787-807
818-838
886-906
933-953
1662-1682
1810-1830
1833-1853
1855-1875
1886-1906
3013-3033</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>8.26</theoretical-pi>
        <molecular-weight>329166.12</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="11116">HCV</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D00944</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>221651</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P26660</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>POLG_HCVJ6</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.4.22.-</synonym>
          <synonym>p23</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019171|Genome polyprotein
MSTNPKPQRKTKRNTNRRPQDVKFPGGGQIVGGVYLLPRRGPRLGVRATRKTSERSQPRG
RRQPIPKDRRSTGKSWGKPGYPWPLYGNEGLGWAGWLLSPRGSRPSWGPNDPRHRSRNVG
KVIDTLTCGFADLMGYIPVVGAPLGGVARALAHGVRVLEDGVNFATGNLPGCSFSIFLLA
LLSCITTPVSAAEVKNISTGYMVTNDCTNDSITWQLQAAVLHVPGCVPCEKVGNTSRCWI
PVSPNVAVQQPGALTQGLRTHIDMVVMSATLCSALYVGDLCGGVMLAAQMFIVSPQHHWF
VQDCNCSIYPGTITGHRMAWDMMMNWSPTATMILAYAMRVPEVIIDIIGGAHWGVMFGLA
YFSMQGAWAKVVVILLLAAGVDAQTHTVGGSTAHNARTLTGMFSLGARQKIQLINTNGSW
HINRTALNCNDSLHTGFLASLFYTHSFNSSGCPERMSACRSIEAFRVGWGALQYEDNVTN
PEDMRPYCWHYPPRQCGVVSASSVCGPVYCFTPSPVVVGTTDRLGAPTYTWGENETDVFL
LNSTRPPQGSWFGCTWMNSTGYTKTCGAPPCRIRADFNASMDLLCPTDCFRKHPDTTYIK
CGSGPWLTPRCLIDYPYRLWHYPCTVNYTIFKIRMYVGGVEHRLTAACNFTRGDRCNLED
RDRSQLSPLLHSTTEWAILPCTYSDLPALSTGLLHLHQNIVDVQFMYGLSPALTKYIVRW
EWVVLLFLLLADARVCACLWMLILLGQAEAALEKLVVLHAASAASCNGFLYFVIFFVAAW
YIKGRVVPLATYSLTGLWSFGLLLLALPQQAYAYDASVHGQIGAALLVLITLFTLTPGYK
TLLSRFLWWLCYLLTLAEAMVQEWAPPMQVRGGRDGIIWAVAIFCPGVVFDITKWLLAVL
GPAYLLKGALTRVPYFVRAHALLRMCTMVRHLAGGRYVQMVLLALGRWTGTYIYDHLTPM
SDWAANGLRDLAVAVEPIIFSPMEKKVIVWGAETAACGDILHGLPVSARLGREVLLGPAD
GYTSKGWSLLAPITAYAQQTRGLLGTIVVSMTGRDKTEQAGEIQVLSTVTQSFLGTTISG
VLWTVYHGAGNKTLAGSRGPVTQMYSSAEGDLVGWPSPPGTKSLEPCTCGAVDLYLVTRN
ADVIPARRRGDKRGALLSPRPLSTLKGSSGGPVLCPRGHAVGVFRAAVCSRGVAKSIDFI
PVETLDIVTRSPTFSDNSTPPAVPQTYQVGYLHAPTGSGKSTKVPVAYAAQGYKVLVLNP
SVAATLGFGAYLSKAHGINPNIRTGVRTVTTGAPITYSTYGKFLADGGCAGGAYDIIICD
ECHAVDSTTILGIGTVLDQAETAGVRLTVLATATPPGSVTTPHPNIEEVALGQEGEIPFY
GRAIPLSYIKGGRHLIFCHSKKKCDELAAALRGMGLNAVAYYRGLDVSVIPTQGDVVVVA
TDALMTGFTGDFDSVIDCNVAVTQVVDFSLDPTFTITTQTVPQDAVSRSQRRGRTGRGRL
GIYRYVSTGERASGMFDSVVLCECYDAGAAWYELTPAETTVRLRAYFNTPGLPVCQDHLE
FWEAVFTGLTHIDAHFLSQTKQSGENFAYLTAYQATVCARAKAPPPSWDVMWKCLTRLKP
TLVGPTPLLYRLGSVTNEVTLTHPVTKYIATCMQADLEVMTSTWVLAGGVLAAVAAYCLA
TGCVCIIGRLHVNQRAVVAPDKEVLYEAFDEMEECASRAALIEEGQRIAEMLKSKIQGLL
QQASKQAQDIQPAVQASWPKVEQFWAKHMWNFISGIQYLAGLSTLPGNPAVASMMAFSAA
LTSPLSTSTTILLNILGGWLASQIAPPAGATGFVVSGLVGAAVGSIGLGKVLVDILAGYG
AGISGALVAFKIMSGEKPSMEDVVNLLPGILSPGALVVGVICAAILRRHVGPGEGAVQWM
NRLIAFASRGNHVAPTHYVTESDASQRVTQLLGSLTITSLLRRLHNWITEDCPIPCSGSW
LRDVWDWVCTILTDFKNWLTSKLFPKMPGLPFISCQKGYKGVWAGTGIMTTRCPCGANIS
GNVRLGSMRITGPKTCMNIWQGTFPINCYTEGQCVPKPAPNFKIAIWRVAASEYAEVTQH
GSYHYITGLTTDNLKVPCQLPSPEFFSWVDGVQIHRFAPIPKPFFRDEVSFCVGLNSFVV
GSQLPCDPEPDTDVLTSMLTDPSHITAETAARRLARGSPPSEASSSASQLSAPSLRATCT
THGKAYDVDMVDANLFMGGDVTRIESESKVVVLDSLDPMVEERSDLEPSIPSEYMLPKKR
FPPALPAWARPDYNPPLVESWKRPDYQPATVAGCALPPPKKTPTPPPRRRRTVGLSESSI
ADALQQLAIKSFGQPPPSGDSGLSTGADAADSGSRTPPDELALSETGSISSMPPLEGEPG
DPDLEPEQVELQPPPQGGVVTPGSGSGSWSTCSEEDDSVVCCSMSYSWTGALITPCSPEE
EKLPINPLSNSLLRYHNKVYCTTSKSASLRAKKVTFDRMQALDAHYDSVLKDIKLAASKV
TARLLTLEEACQLTPPHSARSKYGFGAKEVRSLSGRAVNHIKSVWKDLLEDTQTPIPTTI
MAKNEVFCVDPTKGGKKAARLIVYPDLGVRVCEKMALYDITQKLPQAVMGASYGFQYSPA
QRVEFLLKAWAEKKDPMGFSYDTRCFDSTVTERDIRTEESIYRACSLPEEAHTAIHSLTE
RLYVGGPMFNSKGQTCGYRRCRASGVLTTSMGNTITCYVKALAACKAAGIIAPTMLVCGD
DLVVISESQGTEEDERNLRAFTEAMTRYSAPPGDPPRPEYDLELITSCSSNVSVALGPQG
RRRYYLTRDPTTPIARAAWETVRHSPVNSWLGNIIQYAPTIWARMVLMTHFFSILMAQDT
LDQNLNFEMYGAVYSVSPLDLPAIIERLHGLDAFSLHTYTPHELTRVASALRKLGAPPLR
AWKSRARAVRASLISRGGRAAVCGRYLFNWAVKTKLKLTPLPEARLLDLSSWFTVGAGGG
DIYHSVSRARPRLLLLGLLLLFVGVGLFLLPAR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003428|9102 bp
ATGAGCACAAATCCTAAACCTCAAAGAAAAACCAAAAGAAACACCAACCGTCGCCCACAA
GACGTTAAGTTTCCGGGCGGCGGCCAGATCGTTGGCGGAGTATACTTGTTGCCGCGCAGG
GGCCCCAGGTTGGGTGTGCGCGCGACAAGGAAGACTTCGGAGCGGTCCCAGCCACGTGGA
AGGCGCCAGCCCATCCCTAAGGATCGGCGCTCCACTGGCAAATCCTGGGGAAAACCAGGA
TACCCCTGGCCCCTATACGGGAATGAGGGACTCGGCTGGGCAGGATGGCTCCTGTCCCCC
CGAGGTTCCCGTCCCTCTTGGGGCCCCAATGACCCCCGGCATAGGTCCCGCAACGTGGGT
AAGGTCATCGATACCCTAACGTGCGGCTTTGCCGACCTCATGGGGTACATCCCTGTCGTA
GGCGCCCCGCTCGGCGGCGTCGCCAGAGCTCTCGCGCATGGCGTGAGAGTCCTGGAGGAC
GGGGTTAATTTTGCAACAGGGAACTTACCCGGTTGCTCCTTTTCTATCTTCTTGCTGGCC
CTGCTGTCCTGCATCACCACCCCGGTCTCCGCTGCCGAAGTGAAGAACATCAGTACCGGC
TACATGGTGACCAACGACTGCACCAATGATAGCATTACCTGGCAACTCCAGGCTGCTGTC
CTCCACGTCCCCGGGTGCGTCCCGTGCGAGAAAGTGGGGAATACATCTCGGTGCTGGATA
CCGGTCTCACCGAATGTGGCCGTGCAGCAGCCCGGCGCCCTCACGCAGGGCTTACGGACG
CACATTGACATGGTTGTGATGTCCGCCACGCTCTGCTCCGCTCTTTACGTGGGGGACCTC
TGCGGTGGGGTGATGCTTGCAGCCCAGATGTTCATTGTCTCGCCACAGCACCACTGGTTT
GTGCAAGACTGCAATTGCTCCATCTACCCTGGTACCATCACTGGACACCGCATGGCGTGG
GACATGATGATGAACTGGTCGCCCACGGCTACCATGATCCTGGCGTACGCGATGCGCGTC
CCCGAGGTCATCATAGACATCATTGGCGGGGCTCATTGGGGCGTCATGTTCGGCTTAGCC
TACTTCTCTATGCAGGGAGCGTGGGCAAAAGTCGTTGTCATTCTTTTGCTGGCCGCCGGG
GTGGACGCGCAAACCCATACCGTTGGGGGTTCTACCGCGCATAACGCCAGGACCCTCACC
GGCATGTTCTCCCTTGGTGCCAGGCAGAAAATCCAGCTCATCAACACCAATGGCAGTTGG
CACATCAACCGCACCGCCCTGAACTGCAATGACTCTTTGCACACCGGCTTCCTCGCGTCA
CTGTTCTACACCCACAGCTTCAACTCGTCAGGATGTCCCGAACGCATGTCCGCCTGCCGC
AGTATCGAGGCCTTTCGGGTGGGATGGGGCGCCTTACAATATGAGGACAATGTCACCAAT
CCAGAGGATATGAGACCGTATTGCTGGCACTACCCACCAAGACAGTGTGGTGTAGTCTCC
GCGAGCTCTGTGTGTGGCCCAGTGTACTGTTTCACCCCCAGCCCAGTAGTAGTGGGTACG
ACCGATAGACTTGGAGCGCCCACTTACACGTGGGGGGAGAATGAGACAGATGTCTTCCTA
TTGAACAGCACTCGACCACCGCAGGGGTCATGGTTCGGCTGCACGTGGATGAACTCCACT
GGCTACACCAAGACTTGCGGCGCACCACCCTGCCGCATTAGAGCTGACTTCAATGCCAGC
ATGGACTTGTTGTGCCCCACGGACTGTTTTAGGAAGCATCCTGATACCACCTACATCAAA
TGTGGCTCTGGGCCCTGGCTCACGCCAAGGTGCCTGATCGACTACCCCTACAGGCTCTGG
CATTACCCCTGCACAGTTAACTATACCATCTTCAAAATAAGGATGTATGTGGGGGGGGTC
GAGCACAGGCTCACGGCTGCGTGCAATTTCACTCGTGGGGATCGTTGCAACTTGGAGGAC
AGAGACAGAAGTCAACTGTCTCCTTTGCTGCACTCCACCACGGAGTGGGCCATTTTACCT
TGCACTTACTCGGACCTGCCCGCCTTGTCGACTGGTCTTCTCCACCTCCACCAAAACATC
GTGGACGTGCAATTCATGTATGGCCTATCACCTGCTCTCACAAAATACATCGTCCGATGG
GAGTGGGTAGTACTCTTATTCCTGCTCTTAGCGGACGCCAGGGTTTGCGCCTGCTTATGG
ATGCTCATCTTGTTGGGCCAGGCCGAAGCAGCACTAGAGAAGTTGGTCGTCTTGCACGCT
GCGAGCGCAGCTAGCTGCAATGGCTTCCTATACTTTGTCATCTTTTTCGTGGCTGCTTGG
TACATCAAGGGTCGGGTAGTCCCCTTGGCTACTTATTCCCTCACTGGCCTATGGTCCTTT
GGCCTACTGCTCCTAGCATTGCCCCAACAGGCTTATGCTTATGACGCATCTGTACATGGT
CAGATAGGAGCAGCTCTGTTGGTACTGATCACTCTCTTTACACTCACCCCCGGGTATAAG
ACCCTTCTCAGCCGGTTTCTGTGGTGGTTGTGCTATCTTCTGACCCTGGCGGAAGCTATG
GTCCAGGAGTGGGCACCACCTATGCAGGTGCGCGGTGGCCGTGATGGGATCATATGGGCC
GTCGCCATATTCTGCCCGGGTGTGGTGTTTGACATAACCAAGTGGCTCTTGGCGGTGCTT
GGGCCTGCTTATCTCCTAAAAGGTGCTTTGACGCGTGTGCCGTACTTCGTCAGGGCTCAC
GCTCTACTAAGGATGTGCACCATGGTAAGGCATCTCGCGGGGGGTAGGTACGTCCAGATG
GTGCTACTAGCCCTTGGCAGGTGGACTGGCACTTACATCTATGACCACCTCACCCCTATG
TCGGATTGGGCTGCTAATGGCCTGCGGGACTTGGCGGTCGCCGTGGAGCCTATCATCTTC
AGTCCGATGGAGAAAAAAGTCATCGTCTGGGGAGCGGAGACAGCTGCTTGCGGGGATATC
TTACACGGACTTCCCGTGTCCGCCCGACTTGGCCGGGAGGTCCTCCTTGGCCCAGCTGAT
GGCTATACCTCCAAGGGGTGGAGTCTTCTCGCCCCCATCACTGCTTATGCCCAGCAGACA
CGCGGCCTTTTGGGCACCATAGTGGTGAGCATGACGGGGCGCGACAAGACAGAACAGGCC
GGGGAGATTCAGGTCCTGTCCACGGTCACTCAGTCCTTCCTCGGAACAACCATCTCGGGG
GTCTTATGGACTGTCTACCATGGAGCTGGCAACAAGACTCTAGCCGGCTCACGGGGTCCG
GTCACACAGATGTACTCCAGTGCTGAGGGGGACTTAGTGGGGTGGCCCAGCCCCCCCGGG
ACCAAATCTTTGGAGCCGTGCACGTGTGGAGCGGTCGACCTATACCTGGTCACGCGAAAC
GCTGATGTCATCCCGGCTCGAAGACGCGGGGACAAGCGAGGAGCGCTACTCTCCCCGAGA
CCTCTTTCCACCTTGAAGGGGTCCTCGGGGGGCCCGGTGCTCTGCCCCAGAGGCCACGCT
GTCGGGGTCTTCCGGGCAGCCGTGTGCTCCCGGGGCGTGGCCAAGTCCATAGATTTTATC
CCCGTTGAGACACTTGACATCGTCACTCGGTCCCCCACCTTTAGTGACAACAGCACACCA
CCTGCTGTGCCCCAAACTTATCAGGTCGGGTACTTACATGCCCCGACTGGTAGTGGAAAG
AGCACCAAAGTCCCTGTCGCGTATGCCGCTCAGGGGTACAAAGTGCTAGTGCTTAATCCC
TCGGTGGCTGCCACCCTGGGGTTTGGGGCGTACTTGTCCAAGGCACATGGCATCAATCCC
AACATTAGGACTGGGGTCAGGACTGTGACGACCGGGGCGCCCATCACGTACTCCACATAT
GGCAAATTCCTCGCCGATGGGGGCTGCGCAGGCGGCGCCTATGACATCATCATATGCGAT
GAATGCCATGCCGTGGACTCTACCACCATTCTCGGCATCGGAACAGTCCTCGATCAAGCA
GAGACAGCCGGGGTCAGGCTAACTGTACTGGCTACGGCTACGCCCCCCGGGTCAGTGACA
ACCCCCCACCCCAACATAGAGGAGGTGGCCCTCGGGCAGGAGGGTGAGATCCCCTTCTAT
GGGAGGGCGATTCCCCTGTCATACATCAAGGGAGGAAGACACTTGATCTTCTGCCACTCA
AAGAAAAAGTGTGACGAGCTCGCGGCGGCCCTTCGGGGTATGGGCTTGAACGCAGTGGCA
TACTACAGAGGGCTGGACGTCTCCGTAATACCAACTCAGGGAGACGTAGTGGTCGTCGCC
ACCGACGCCCTCATGACGGGGTTTACTGGAGACTTTGACTCCGTGATCGACTGCAACGTA
GCGGTCACTCAAGTTGTAGACTTCAGCTTGGACCCCACATTCACCATAACCACACAGACT
GTCCCTCAAGACGCTGTCTCACGTAGCCAGCGCCGGGGCCGCACGGGCAGGGGAAGACTG
GGTATTTATAGGTATGTTTCCACTGGTGAGCGAGCCTCAGGAATGTTTGACAGTGTAGTG
CTCTGCGAGTGCTACGATGCAGGGGCCGCATGGTATGAGCTCACACCAGCGGAGACCACC
GTCAGGCTCAGAGCATATTTCAACACACCTGGTTTGCCTGTGTGCCAAGACCATCTTGAG
TTTTGGGAGGCAGTTTTCACCGGCCTCACACACATAGATGCCCACTTCCTTTCCCAAACA
AAGCAATCGGGGGAAAATTTCGCATACTTAACAGCCTACCAGGCTACAGTGTGCGCTAGG
GCCAAAGCCCCCCCCCCGTCCTGGGACGTCATGTGGAAGTGTTTGACTCGACTCAAGCCC
ACACTCGTGGGCCCCACACCTCTCCTGTACCGCTTGGGCTCTGTTACCAACGAGGTCACC
CTCACGCATCCTGTGACGAAATACATCGCCACCTGCATGCAAGCCGACCTTGAGGTCATG
ACCAGCACGTGGGTCTTAGCTGGGGGGGTCTTGGCGGCCGTCGCCGCGTACTGCCTGGCG
ACCGGGTGTGTTTGCATCATCGGCCGCTTGCACGTTAACCAGCGAGCCGTCGTTGCACCG
GACAAGGAGGTCCTCTATGAGGCTTTTGATGAGATGGAGGAATGTGCCTCTAGAGCGGCT
CTCATTGAAGAGGGGCAGCGGATAGCCGAGATGCTGAAGTCCAAGATCCAAGGCTTATTG
CAGCAAGCTTCCAAACAAGCTCAAGACATACAACCCGCTGTGCAGGCTTCTTGGCCCAAG
GTAGAGCAATTCTGGGCCAAACACATGTGGAACTTCATCAGCGGCATTCAATACCTCGCA
GGACTATCAACACTGCCAGGGAACCCTGCTGTAGCTTCCATGATGGCATTCAGTGCCGCC
CTCACCAGTCCGTTGTCAACTAGCACCACTATCCTTCTCAACATTTTGGGGGGCTGGCTA
GCATCCCAAATTGCGCCTCCCGCGGGGGCTACCGGCTTCGTCGTCAGTGGCCTGGTGGGG
GCTGCCGTAGGCAGCATAGGCTTGGGTAAGGTGCTGGTGGACATCCTGGCAGGGTATGGT
GCGGGCATTTCGGGGGCTCTCGTCGCATTCAAGATCATGTCTGGCGAGAAGCCCTCCATG
GAGGATGTTGTCAACCTGCTGCCTGGAATTCTGTCTCCGGGTGCCCTGGTGGTGGGAGTC
ATCTGCGCGGCCATCCTGCGCCGACACGTGGGACCGGGGGAAGGCGCTGTCCAATGGATG
AATAGGCTCATTGCCTTTGCTTCCAGAGGAAACCACGTCGCCCCCACCCACTACGTGACG
GAGTCGGATGCGTCGCAGCGTGTGACCCAACTACTTGGCTCCCTTACCATAACCAGCCTG
CTCAGGAGACTCCACAACTGGATTACTGAAGACTGCCCCATCCCATGCAGCGGCTCGTGG
CTCCGCGATGTGTGGGATTGGGTTTGCACCATCCTAACAGACTTTAAAAACTGGCTGACC
TCCAAATTGTTCCCAAAGATGCCTGGTCTCCCCTTTATCTCTTGTCAAAAGGGGTACAAG
GGCGTGTGGGCTGGCACTGGTATCATGACCACACGGTGTCCTTGCGGCGCCAATATCTCT
GGCAATGTCCGCCTGGGCTCCATGAGAATTACGGGGCCCAAAACCTGCATGAATATCTGG
CAGGGGACCTTTCCCATCAATTGTTACACGGAGGGCCAGTGCGTGCCGAAACCCGCACCA
AACTTTAAGATCGCCATCTGGAGGGTGGCGGCCTCAGAGTACGCGGAGGTGACGCAGCAC
GGGTCATACCACTACATAACAGGACTTACCACTGATAACTTGAAAGTTCCTTGCCAACTA
CCTTCTCCAGAGTTCTTTTCCTGGGTGGACGGAGTGCAGATCCATAGGTTTGCCCCCATA
CCGAAGCCGTTTTTTCGGGATGAGGTCTCGTTCTGCGTTGGGCTTAATTCATTTGTCGTC
GGGTCTCAGCTCCCTTGCGATCCTGAACCTGACACAGACGTATTGACGTCCATGCTAACA
GACCCATCCCATATCACGGCGGAGACTGCAGCGCGGCGTTTGGCACGGGGGTCACCCCCG
TCCGAGGCAAGCTCCTCAGCGAGCCAGCTATCGGCACCATCGCTGCGAGCCACCTGCACC
ACCCACGGCAAGGCCTATGATGTGGACATGGTGGATGCCAACCTGTTCATGGGGGGCGAT
GTGACCCGGATAGAGTCTGAGTCCAAAGTGGTCGTTCTGGACTCTCTCGACCCAATGGTC
GAAGAAAGGAGCGACCTTGAGCCTTCGATACCATCGGAATATATGCTCCCCAAGAAGAGA
TTCCCACCAGCCTTACCGGCTTGGGCACGGCCTGATTACAACCCACCGCTTGTGGAATCG
TGGAAGAGGCCAGATTACCAACCGGCCACTGTTGCGGGCTGCGCTCTCCCCCCCCCTAAG
AAAACCCCGACGCCTCCCCCAAGGAGACGCCGGACAGTGGGTCTGAGTGAGAGCTCCATA
GCAGATGCCCTACAACAGCTGGCCATCAAGTCCTTTGGCCAGCCCCCCCCAAGCGGCGAT
TCAGGCCTTTCCACGGGGGCGGACGCAGCCGATTCCGGCAGTCGGACGCCCCCCGATGAG
TTGGCCCTTTCGGAGACAGGTTCCATCTCCTCCATGCCCCCTCTCGAGGGGGAGCCTGGA
GATCCAGACTTGGAGCCTGAGCAGGTAGAGCTTCAACCTCCCCCCCAGGGGGGGGTGGTA
ACCCCCGGCTCAGGCTCGGGGTCTTGGTCTACTTGCTCCGAGGAGGACGACTCCGTCGTG
TGCTGCTCCATGTCATACTCCTGGACCGGGGCTCTAATAACTCCTTGTAGCCCCGAAGAG
GAAAAGTTGCCAATTAACCCCTTGAGCAACTCCCTGTTGCGATATCACAACAAGGTGTAC
TGTACCACATCAAAGAGCGCCTCATTAAGGGCTAAAAAGGTAACTTTTGATAGGATGCAA
GCGCTCGACGCTCATTATGACTCAGTCTTGAAGGACATTAAGCTAGCGGCCTCCAAGGTC
ACCGCAAGGCTTCTCACTTTAGAGGAGGCCTGCCAGTTAACTCCACCCCACTCTGCAAGA
TCCAAGTATGGGTTTGGGGCTAAGGAGGTCCGCAGCTTGTCCGGGAGAGCCGTTAACCAC
ATCAAGTCCGTGTGGAAGGACCTCCTGGAAGACACACAAACACCAATTCCTACAACCATC
ATGGCCAAAAATGAGGTGTTCTGCGTGGACCCCACCAAGGGGGGTAAGAAAGCAGCTCGC
CTTATCGTTTACCCTGACCTCGGCGTCAGGGTCTGCGAGAAAATGGCCCTTTATGATATC
ACACAAAAGCTTCCTCAGGCGGTGATGGGGGCTTCTTATGGATTCCAGTACTCCCCCGCT
CAGCGGGTGGAGTTTCTCTTGAAGGCATGGGCGGAAAAGAAAGACCCTATGGGTTTTTCG
TATGATACCCGATGCTTTGACTCAACCGTCACTGAGAGAGACATCAGGACTGAGGAGTCC
ATATATCGGGCTTGTTCCTTGCCCGAGGAGGCCCACACTGCCATACACTCACTGACTGAG
AGACTTTACGTGGGAGGGCCCATGTTCAACAGCAAGGGCCAGACCTGCGGGTACAGGCGT
TGCCGCGCCAGCGGGGTGCTTACCACTAGCATGGGGAACACCATCACATGCTATGTGAAA
GCCTTAGCGGCCTGTAAGGCTGCAGGGATAATTGCGCCCACAATGCTGGTATGCGGCGAT
GACTTGGTTGTCATCTCAGAGAGCCAGGGGACCGAGGAGGACGAGCGGAACCTGAGAGCC
TTCACGGAGGCTATGACCAGGTATTCTGCCCCTCCTGGTGACCCCCCCAGACCGGAATAT
GACCTGGAGCTGATAACATCTTGCTCCTCAAATGTGTCTGTGGCGTTGGGCCCACAAGGC
CGCCGCAGATACTACCTGACCAGAGACCCTACCACTCCAATCGCCCGGGCTGCCTGGGAA
ACAGTTAGACACTCCCCTGTCAATTCATGGCTAGGAAACATCATCCAGTACGCCCCAACC
ATATGGGCTCGCATGGTCCTGATGACACACTTCTTCTCCATTCTCATGGCCCAAGATACT
CTGGACCAGAACCTCAACTTTGAGATGTACGGAGCGGTGTACTCCGTGAGTCCCTTGGAC
CTCCCAGCCATAATTGAAAGGTTACACGGGCTTGACGCTTTCTCTCTGCACACATACACT
CCCCACGAACTGACACGGGTGGCTTCAGCCCTCAGAAAACTTGGGGCGCCACCCCTCAGA
GCGTGGAAGAGCCGGGCACGTGCAGTCAGGGCGTCCCTCATCTCCCGTGGGGGGAGAGCG
GCCGTTTGCGGCCGATATCTCTTCAACTGGGCGGTGAAGACCAAGCTCAAACTCACTCCA
TTGCCGGAAGCGCGCCTCCTGGATTTATCCAGCTGGTTCACTGTCGGCGCCGGCGGGGGC
GACATTTATCACAGCGTGTCGCGTGCCCGACCCCGCTTATTACTCCTTGGCCTACTCCTA
CTTTTTGTAGGGGTAGGCCTTTTCCTACTCCCCGCTCGGTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01543</identifier>
            <name>HCV_capsid</name>
          </pfam>
          <pfam>
            <identifier>PF01542</identifier>
            <name>HCV_core</name>
          </pfam>
          <pfam>
            <identifier>PF01539</identifier>
            <name>HCV_env</name>
          </pfam>
          <pfam>
            <identifier>PF01560</identifier>
            <name>HCV_NS1</name>
          </pfam>
          <pfam>
            <identifier>PF01538</identifier>
            <name>HCV_NS2</name>
          </pfam>
          <pfam>
            <identifier>PF01006</identifier>
            <name>HCV_NS4a</name>
          </pfam>
          <pfam>
            <identifier>PF01001</identifier>
            <name>HCV_NS4b</name>
          </pfam>
          <pfam>
            <identifier>PF01506</identifier>
            <name>HCV_NS5a</name>
          </pfam>
          <pfam>
            <identifier>PF08300</identifier>
            <name>HCV_NS5a_1a</name>
          </pfam>
          <pfam>
            <identifier>PF08301</identifier>
            <name>HCV_NS5a_1b</name>
          </pfam>
          <pfam>
            <identifier>PF02907</identifier>
            <name>Peptidase_S29</name>
          </pfam>
          <pfam>
            <identifier>PF00998</identifier>
            <name>RdRP_3</name>
          </pfam>
          <pfam>
            <identifier>PF07652</identifier>
            <name>Flavi_DEAD</name>
          </pfam>
          <pfam>
            <identifier>PF12941</identifier>
            <name>HCV_NS5a_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell endoplasmic reticulum membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell lipid particle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell mitochondrial membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell perinuclear region of cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>host cell plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral to membrane of host cell</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>viral envelope</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>viral nucleocapsid</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>virion membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP-dependent helicase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cysteine-type endopeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-directed RNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>serine-type endopeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>clathrin-mediated endocytosis of virus by host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fusion of virus membrane with host endosome membrane</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>induction by virus of host autophagy</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>modulation by virus of host G1/S transition checkpoint</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pore formation by virus in membrane of host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein oligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>suppression by virus of host MAVS activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>suppression by virus of host STAT1 activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>suppression by virus of host TRAF activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>suppression by virus of host type I interferon-mediated signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transformation of host cell by virus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral RNA genome replication</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>virion attachment to host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>